1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Monoclonal Antibodies 1.2.3 Small-Molecules 1.2.4 Immunotoxins 1.2.5 Others 1.3 Market by Application 1.3.1 Global Injectable Targeted Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Homecare 1.3.4 Specialty Clinics 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Injectable Targeted Therapy Market Perspective (2016-2027) 2.2 Injectable Targeted Therapy Growth Trends by Regions 2.2.1 Injectable Targeted Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Injectable Targeted Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Injectable Targeted Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Injectable Targeted Therapy Industry Dynamic 2.3.1 Injectable Targeted Therapy Market Trends 2.3.2 Injectable Targeted Therapy Market Drivers 2.3.3 Injectable Targeted Therapy Market Challenges 2.3.4 Injectable Targeted Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Injectable Targeted Therapy Players by Revenue 3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2016-2021) 3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue 3.4 Global Injectable Targeted Therapy Market Concentration Ratio 3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2020 3.5 Injectable Targeted Therapy Key Players Head office and Area Served 3.6 Key Players Injectable Targeted Therapy Product Solution and Service 3.7 Date of Enter into Injectable Targeted Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Injectable Targeted Therapy Breakdown Data by Type 4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2016-2021) 4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2022-2027) 5 Injectable Targeted Therapy Breakdown Data by Application 5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2016-2021) 5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Injectable Targeted Therapy Market Size (2016-2027) 6.2 North America Injectable Targeted Therapy Market Size by Type 6.2.1 North America Injectable Targeted Therapy Market Size by Type (2016-2021) 6.2.2 North America Injectable Targeted Therapy Market Size by Type (2022-2027) 6.2.3 North America Injectable Targeted Therapy Market Size by Type (2016-2027) 6.3 North America Injectable Targeted Therapy Market Size by Application 6.3.1 North America Injectable Targeted Therapy Market Size by Application (2016-2021) 6.3.2 North America Injectable Targeted Therapy Market Size by Application (2022-2027) 6.3.3 North America Injectable Targeted Therapy Market Size by Application (2016-2027) 6.4 North America Injectable Targeted Therapy Market Size by Country 6.4.1 North America Injectable Targeted Therapy Market Size by Country (2016-2021) 6.4.2 North America Injectable Targeted Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Injectable Targeted Therapy Market Size (2016-2027) 7.2 Europe Injectable Targeted Therapy Market Size by Type 7.2.1 Europe Injectable Targeted Therapy Market Size by Type (2016-2021) 7.2.2 Europe Injectable Targeted Therapy Market Size by Type (2022-2027) 7.2.3 Europe Injectable Targeted Therapy Market Size by Type (2016-2027) 7.3 Europe Injectable Targeted Therapy Market Size by Application 7.3.1 Europe Injectable Targeted Therapy Market Size by Application (2016-2021) 7.3.2 Europe Injectable Targeted Therapy Market Size by Application (2022-2027) 7.3.3 Europe Injectable Targeted Therapy Market Size by Application (2016-2027) 7.4 Europe Injectable Targeted Therapy Market Size by Country 7.4.1 Europe Injectable Targeted Therapy Market Size by Country (2016-2021) 7.4.2 Europe Injectable Targeted Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2016-2027) 8.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type 8.2.1 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application 8.3.1 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region 8.4.1 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Injectable Targeted Therapy Market Size (2016-2027) 9.2 Latin America Injectable Targeted Therapy Market Size by Type 9.2.1 Latin America Injectable Targeted Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Injectable Targeted Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Injectable Targeted Therapy Market Size by Type (2016-2027) 9.3 Latin America Injectable Targeted Therapy Market Size by Application 9.3.1 Latin America Injectable Targeted Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Injectable Targeted Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Injectable Targeted Therapy Market Size by Application (2016-2027) 9.4 Latin America Injectable Targeted Therapy Market Size by Country 9.4.1 Latin America Injectable Targeted Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Injectable Targeted Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2016-2027) 10.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type 10.2.1 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application 10.3.1 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country 10.4.1 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Injectable Targeted Therapy Introduction 11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2016-2021) 11.1.5 Novartis Recent Development 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Injectable Targeted Therapy Introduction 11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2016-2021) 11.2.5 Sanofi Recent Development 11.3 GSK 11.3.1 GSK Company Details 11.3.2 GSK Business Overview 11.3.3 GSK Injectable Targeted Therapy Introduction 11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2016-2021) 11.3.5 GSK Recent Development 11.4 Bayer 11.4.1 Bayer Company Details 11.4.2 Bayer Business Overview 11.4.3 Bayer Injectable Targeted Therapy Introduction 11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2016-2021) 11.4.5 Bayer Recent Development 11.5 Amgen 11.5.1 Amgen Company Details 11.5.2 Amgen Business Overview 11.5.3 Amgen Injectable Targeted Therapy Introduction 11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2016-2021) 11.5.5 Amgen Recent Development 11.6 Merck 11.6.1 Merck Company Details 11.6.2 Merck Business Overview 11.6.3 Merck Injectable Targeted Therapy Introduction 11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2016-2021) 11.6.5 Merck Recent Development 11.7 AbbiVie 11.7.1 AbbiVie Company Details 11.7.2 AbbiVie Business Overview 11.7.3 AbbiVie Injectable Targeted Therapy Introduction 11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2016-2021) 11.7.5 AbbiVie Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Details 11.8.2 AstraZeneca Business Overview 11.8.3 AstraZeneca Injectable Targeted Therapy Introduction 11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2016-2021) 11.8.5 AstraZeneca Recent Development 11.9 Teva 11.9.1 Teva Company Details 11.9.2 Teva Business Overview 11.9.3 Teva Injectable Targeted Therapy Introduction 11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2016-2021) 11.9.5 Teva Recent Development 11.10 Roche 11.10.1 Roche Company Details 11.10.2 Roche Business Overview 11.10.3 Roche Injectable Targeted Therapy Introduction 11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2016-2021) 11.10.5 Roche Recent Development 11.11 Pfizer 11.11.1 Pfizer Company Details 11.11.2 Pfizer Business Overview 11.11.3 Pfizer Injectable Targeted Therapy Introduction 11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2016-2021) 11.11.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Injectable Targeted Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Small-Molecules Table 4. Key Players of Immunotoxins Table 5. Key Players of Others Table 6. Global Injectable Targeted Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Injectable Targeted Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Injectable Targeted Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Injectable Targeted Therapy Market Share by Regions (2016-2021) Table 10. Global Injectable Targeted Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Injectable Targeted Therapy Market Share by Regions (2022-2027) Table 12. Injectable Targeted Therapy Market Trends Table 13. Injectable Targeted Therapy Market Drivers Table 14. Injectable Targeted Therapy Market Challenges Table 15. Injectable Targeted Therapy Market Restraints Table 16. Global Injectable Targeted Therapy Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Injectable Targeted Therapy Market Share by Players (2016-2021) Table 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Targeted Therapy as of 2020) Table 19. Ranking of Global Top Injectable Targeted Therapy Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Injectable Targeted Therapy Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Injectable Targeted Therapy Product Solution and Service Table 23. Date of Enter into Injectable Targeted Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 26. Global Injectable Targeted Therapy Revenue Market Share by Type (2016-2021) Table 27. Global Injectable Targeted Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Injectable Targeted Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Injectable Targeted Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Injectable Targeted Therapy Revenue Market Share by Application (2016-2021) Table 31. Global Injectable Targeted Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Injectable Targeted Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 34. North America Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 36. North America Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million) Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Injectable Targeted Therapy Product Table 66. Novartis Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 67. Novartis Recent Development Table 68. Sanofi Company Details Table 69. Sanofi Business Overview Table 70. Sanofi Injectable Targeted Therapy Product Table 71. Sanofi Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 72. Sanofi Recent Development Table 73. GSK Company Details Table 74. GSK Business Overview Table 75. GSK Injectable Targeted Therapy Product Table 76. GSK Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 77. GSK Recent Development Table 78. Bayer Company Details Table 79. Bayer Business Overview Table 80. Bayer Injectable Targeted Therapy Product Table 81. Bayer Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 82. Bayer Recent Development Table 83. Amgen Company Details Table 84. Amgen Business Overview Table 85. Amgen Injectable Targeted Therapy Product Table 86. Amgen Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 87. Amgen Recent Development Table 88. Merck Company Details Table 89. Merck Business Overview Table 90. Merck Injectable Targeted Therapy Product Table 91. Merck Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 92. Merck Recent Development Table 93. AbbiVie Company Details Table 94. AbbiVie Business Overview Table 95. AbbiVie Injectable Targeted Therapy Product Table 96. AbbiVie Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 97. AbbiVie Recent Development Table 98. AstraZeneca Company Details Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 101. AstraZeneca Recent Development Table 102. Teva Company Details Table 103. Teva Business Overview Table 104. Teva Injectable Targeted Therapy Product Table 105. Teva Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 106. Teva Recent Development Table 107. Roche Company Details Table 108. Roche Business Overview Table 109. Roche Injectable Targeted Therapy Product Table 110. Roche Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 111. Roche Recent Development Table 112. Pfizer Company Details Table 113. Pfizer Business Overview Table 114. Pfizer Injectable Targeted Therapy Product Table 115. Pfizer Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million) Table 116. Pfizer Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Injectable Targeted Therapy Market Share by Type: 2020 VS 2027 Figure 2. Monoclonal Antibodies Features Figure 3. Small-Molecules Features Figure 4. Immunotoxins Features Figure 5. Others Features Figure 6. Global Injectable Targeted Therapy Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Homecare Case Studies Figure 9. Specialty Clinics Case Studies Figure 10. Others Case Studies Figure 11. Injectable Targeted Therapy Report Years Considered Figure 12. Global Injectable Targeted Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Injectable Targeted Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Injectable Targeted Therapy Market Share by Regions: 2020 VS 2027 Figure 15. Global Injectable Targeted Therapy Market Share by Regions (2022-2027) Figure 16. Global Injectable Targeted Therapy Market Share by Players in 2020 Figure 17. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Targeted Therapy as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2020 Figure 19. Global Injectable Targeted Therapy Revenue Market Share by Type (2016-2021) Figure 20. Global Injectable Targeted Therapy Revenue Market Share by Type (2022-2027) Figure 21. North America Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Injectable Targeted Therapy Market Share by Type (2016-2027) Figure 23. North America Injectable Targeted Therapy Market Share by Application (2016-2027) Figure 24. North America Injectable Targeted Therapy Market Share by Country (2016-2027) Figure 25. United States Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Injectable Targeted Therapy Market Share by Type (2016-2027) Figure 29. Europe Injectable Targeted Therapy Market Share by Application (2016-2027) Figure 30. Europe Injectable Targeted Therapy Market Share by Country (2016-2027) Figure 31. Germany Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Injectable Targeted Therapy Market Share by Type (2016-2027) Figure 39. Asia-Pacific Injectable Targeted Therapy Market Share by Application (2016-2027) Figure 40. Asia-Pacific Injectable Targeted Therapy Market Share by Region (2016-2027) Figure 41. China Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Injectable Targeted Therapy Market Share by Type (2016-2027) Figure 49. Latin America Injectable Targeted Therapy Market Share by Application (2016-2027) Figure 50. Latin America Injectable Targeted Therapy Market Share by Country (2016-2027) Figure 51. Mexico Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Injectable Targeted Therapy Market Share by Type (2016-2027) Figure 55. Middle East & Africa Injectable Targeted Therapy Market Share by Application (2016-2027) Figure 56. Middle East & Africa Injectable Targeted Therapy Market Share by Country (2016-2027) Figure 57. Turkey Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Novartis Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 61. Sanofi Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 62. GSK Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 63. Bayer Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 64. Amgen Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 65. Merck Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 66. AbbiVie Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 67. AstraZeneca Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 68. Teva Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 69. Roche Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 70. Pfizer Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Novartis Sanofi GSK Bayer Amgen Merck AbbiVie AstraZeneca Teva Roche Pfizer